Acamprosate Calcium
- Product NDC
- 10135-636
- 11-digit product format
- 101350636
- Labeler code
- 10135
- Product ID
- 10135-636_c9c9c07d-25f5-40e2-b40a-1d1942dd640a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acamprosate Calcium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA202229
- Marketing category
- ANDA
- Marketing start
- 2016-08-01
- Marketing end
- 0000-00-00
- Substance
- ACAMPROSATE CALCIUM
- Active strength
- 333 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-636-32 | Acamprosate Calcium | 180 in 1 BOTTLE | TABLET, DELAYED RELEASE | 180 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-636 | ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [MARLEX PHARMACEUTICALS INC] | 3 | Legacy NDC, 1 package rows | 20191112_a815699f-90ee-41ba-838c-11951aeda90f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10135-636-32 | 10135063632 | 180 in 1 BOTTLE | Historical |